Cart
sales@molnova.com
Hydroxyurea
CAS No. 127-07-1
Hydroxyurea ( NCI C04831; NSC 32065 )
Catalog No. M11135 CAS No. 127-07-1
Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 41 | In Stock |
|
| 1G | 48 | In Stock |
|
Biological Information
-
Product NameHydroxyurea
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
-
DescriptionHydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
-
SynonymsNCI C04831; NSC 32065
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
Recptorribonucleoside diphosphate reductase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number127-07-1
-
Formula Weight76.06
-
Molecular FormulaCH4N2O2
-
Purity>98%(HPLC)
-
SolubilityWater: 15 mg/mL (197.23 mM); DMSO: 15 mg/mL (197.23 mM)
-
SMILESO=C(N)NO
-
Chemical Name1-hydroxyurea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Culligan K, et al. Plant Cell. 2004 May;16(5):1091-104.
molnova catalog
related products
-
TH-287
A potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM.
-
TMPyP4 tosylate
TMPyP4 tosylate is a quadruplex-specific ligand and is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines.
-
SR 11302
SR 11302 is an inhibitor of activator protein-1 (AP-1).
